JP1680565S - - Google Patents
Info
- Publication number
- JP1680565S JP1680565S JPD2020-8709F JP2020008709F JP1680565S JP 1680565 S JP1680565 S JP 1680565S JP 2020008709 F JP2020008709 F JP 2020008709F JP 1680565 S JP1680565 S JP 1680565S
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPD2020-8709F JP1680565S (enExample) | 2020-04-28 | 2020-04-28 | |
| TW109305946F TWD214106S (zh) | 2020-04-28 | 2020-10-28 | 細胞培養袋 |
| US29/756,401 USD979090S1 (en) | 2020-04-28 | 2020-10-28 | Cell culture bag |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPD2020-8709F JP1680565S (enExample) | 2020-04-28 | 2020-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP1680565S true JP1680565S (enExample) | 2021-03-08 |
Family
ID=74845538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JPD2020-8709F Active JP1680565S (enExample) | 2020-04-28 | 2020-04-28 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | USD979090S1 (enExample) |
| JP (1) | JP1680565S (enExample) |
| TW (1) | TWD214106S (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD1010812S1 (en) | 2019-09-11 | 2024-01-09 | Emory University | Pod carrier for deodorizing agents |
| USD1008488S1 (en) * | 2020-04-28 | 2023-12-19 | Toyo Seikan Group Holdings, Ltd. | Cell culture bag |
| JP1680566S (enExample) * | 2020-04-28 | 2021-03-08 | ||
| JP1687139S (enExample) * | 2020-04-28 | 2021-06-07 | ||
| JP1687242S (enExample) * | 2020-04-28 | 2021-06-07 | ||
| JP1680567S (enExample) * | 2020-04-28 | 2021-03-08 | ||
| JP1691598S (enExample) * | 2020-10-13 | 2021-08-02 | ||
| JP1691603S (enExample) | 2020-10-13 | 2021-08-02 | ||
| USD1069159S1 (en) | 2020-10-13 | 2025-04-01 | Toyo Seikan Group Holdings, Ltd. | Cell culture bag |
| USD1069158S1 (en) | 2020-10-13 | 2025-04-01 | Toyo Seikan Group Holdings, Ltd. | Cell culture bag |
| USD1066728S1 (en) * | 2022-09-30 | 2025-03-11 | Maxcyte, Inc. | Bag used for sample or collection |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USD289551S (en) * | 1984-05-10 | 1987-04-28 | Craig Medical Products Ltd. | Urine leg bag |
| USD303574S (en) * | 1987-01-07 | 1989-09-19 | E. R. Squibb & Sons, Inc. | Wound drainage bag |
| USD622375S1 (en) * | 2007-07-19 | 2010-08-24 | Otsuka Pharmaceutical Factory, Inc. | Portion of an infusion solution bag |
| USD670692S1 (en) * | 2011-01-07 | 2012-11-13 | Apple Inc. | Portable display device |
| USD699343S1 (en) * | 2011-12-20 | 2014-02-11 | Alcon Research, Ltd. | Irrigation solution bag |
| USD690828S1 (en) * | 2012-09-17 | 2013-10-01 | Intron Biotechnology, Inc. | Culture media device |
| USD748812S1 (en) * | 2013-04-12 | 2016-02-02 | Corning Incorporated | Arched cell culture flask |
| JPWO2016027800A1 (ja) * | 2014-08-22 | 2017-06-29 | オリンパス株式会社 | 細胞培養バッグ、細胞培養装置および細胞培養容器 |
| US10655097B2 (en) * | 2014-12-22 | 2020-05-19 | Saint-Gobain Performance Plastics Corporation | T-cell culture double bag assembly |
| USD851276S1 (en) * | 2015-06-11 | 2019-06-11 | Yamaha Hatsudoki Kabushiki Kaisha | Placement and cluster sifting cell plate |
| USD785165S1 (en) * | 2015-09-04 | 2017-04-25 | Corpak Medsystems, Inc. | Gastric material collection bag |
| JP1554535S (enExample) | 2015-09-29 | 2017-07-10 | ||
| CN107400631A (zh) * | 2016-05-18 | 2017-11-28 | 纳维再生科技股份有限公司 | 密闭式系统的细胞分离方法、其细胞培养袋及其细胞分离装置 |
| IL249408A0 (en) * | 2016-12-06 | 2017-03-30 | Medimop Medical Projects Ltd | Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom |
| JP1586945S (enExample) | 2017-03-31 | 2020-09-28 | ||
| JP1600530S (enExample) | 2017-09-04 | 2018-03-26 | ||
| JP1617491S (enExample) * | 2018-02-28 | 2021-11-08 | ||
| USD900311S1 (en) * | 2018-05-18 | 2020-10-27 | Baxter International Inc. | Dual chamber flexible container |
| JP7724152B2 (ja) * | 2018-08-21 | 2025-08-15 | フレゼニウス カービ ドイチュラント ゲーエムベーハー | 輸液バッグ |
| USD907238S1 (en) * | 2018-10-31 | 2021-01-05 | Sony Corporation | Embryo culture dish |
| USD908869S1 (en) * | 2019-02-05 | 2021-01-26 | Sun Pharmaceutical Industries Limited | Infusion bag |
| JP2022521982A (ja) * | 2019-02-26 | 2022-04-13 | トルビアン サイエンシズ インコーポレイテッド | アッセイ装置およびその使用方法 |
| USD909572S1 (en) * | 2019-03-11 | 2021-02-02 | Coloplast A/S | Ostomy bag |
-
2020
- 2020-04-28 JP JPD2020-8709F patent/JP1680565S/ja active Active
- 2020-10-28 US US29/756,401 patent/USD979090S1/en active Active
- 2020-10-28 TW TW109305946F patent/TWD214106S/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| USD979090S1 (en) | 2023-02-21 |
| TWD214106S (zh) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP1680565S (enExample) | ||
| JP1687242S (enExample) | ||
| BR102021007058A2 (enExample) | ||
| BR102020022030A2 (enExample) | ||
| AR134288A1 (es) | UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b | |
| AR134282A1 (es) | Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf | |
| AR134271A1 (es) | Variantes de cnp, conjugados y formulaciones de los mismos | |
| AR134276A1 (es) | ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS | |
| AR134275A1 (es) | Anticuerpos cd24 | |
| AR134262A1 (es) | Formulación líquida de agente biológico en almacenamiento estable | |
| AR134263A1 (es) | Tratamiento de covid persistente con composición de vesículas extracelulares | |
| AR134264A1 (es) | Correctores farmacológicos de rodopsina y sus usos | |
| AR134266A1 (es) | Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1 | |
| AR134258A1 (es) | Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina | |
| AR134259A1 (es) | Compuestos de pirimidina bicíclicos, métodos y usos de estos | |
| AR134257A1 (es) | Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina | |
| AR134219A1 (es) | Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos | |
| AR134214A1 (es) | Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central | |
| AR134126A1 (es) | Cubierta de propulsión de energía mareomotriz | |
| AR134104A1 (es) | Compuestos de carbamoilpiridona tricíclicos en puente y usos de estos | |
| AR134110A1 (es) | Inhibidores de ras | |
| AR134093A1 (es) | Proteínas de unión a antígenos anti-cdh17 y sus usos | |
| AR134109A1 (es) | Tapón de elevación | |
| AR134105A1 (es) | Compuestos de carbamoilpiridona tricíclicos en puente y usos de estos | |
| AR134079A1 (es) | Composiciones y métodos de unión a células t |